Findings

What do systematic reviews say?

4,749 questions · 17,858 findings · 1,266 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 4,359 · 24.4%GRADE not reported 2,348 · 13.1%Very low 4,634 · 25.9%Low 4,000 · 22.4%Moderate 2,052 · 11.5%High 465 · 2.6%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Any intervention vs steroid alone or plus levofloxacin

Proportion of participants in whose eyes SEI had disappeared within 21 days of treatment (higher is favored) · epidemic keratoconjunctivitis

1 finding from 1 review

Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Any intervention vs steroid alone or plus levofloxacin

Proportion of participants who discontinued medication and did not develop rebound SEI within 21 days (higher is favored) · epidemic keratoconjunctivitis

It is very uncertain whether any intervention changes proportion of participants who discontinued medication and did not… compared with steroid alone or plus levofloxacin (very low certainty).

1 finding from 1 review

Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis 2022 · Cochrane Headline outcomes only
RR 1.04 [0.94, 1.14]
3 studies · 231 participants
Very low

Any intervention vs steroid alone or plus levofloxacin

Proportion of participants who had evidence of adenoviral eradication within 14 days of treatment (higher is favored) · epidemic keratoconjunctivitis

1 finding from 1 review

Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Any intervention vs steroid alone or plus levofloxacin

Proportion of initially unaffected fellow eyes that had signs/symptoms of infection within 7 days of onset of signs/symptoms in the first eye (lower is favored) · epidemic keratoconjunctivitis

The review found no eligible studies for this question.

1 finding from 1 review

Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Any intervention vs artificial tears or saline

Resolution of symptoms · epidemic keratoconjunctivitis

Any intervention may leads to higher proportion of participants with resolution of symptoms within 10… compared with artificial tears or saline (low certainty).

1 finding from 1 review

Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis 2022 · Cochrane Headline outcomes only
RR 1.15 [1.07, 1.24]
2 studies · 409 participants
Low

Any intervention vs artificial tears or saline

Proportion of participants with resolution of signs within 10 days of treatment (higher is favored) · epidemic keratoconjunctivitis

1 finding from 1 review

Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis 2022 · Cochrane Headline outcomes only
3.19 [2.29, 4.45]
2 studies · 409 participants
Low

Any intervention vs artificial tears or saline

Proportion of participants in whose eyes SEIs had developed within 30 days of treatment initiation (lower is favored) · epidemic keratoconjunctivitis

It is very uncertain whether any intervention changes proportion of participants in whose eyes SEIs had developed within… compared with artificial tears or saline (very low certainty).

1 finding from 1 review

Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis 2022 · Cochrane Headline outcomes only
RR 0.24 [0.1, 0.56]
2 studies · 77 participants
Very low

Any intervention vs artificial tears or saline

Proportion of participants in whose eyes SEI had disappeared within 21 days of treatment (higher is favored) · epidemic keratoconjunctivitis

It is very uncertain whether any intervention changes proportion of participants in whose eyes SEI had disappeared within… compared with artificial tears or saline (very low certainty).

1 finding from 1 review

Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis 2022 · Cochrane Headline outcomes only
RR 1.34 [0.88, 2.04]
2 studies · 156 participants
Very low

Any intervention vs artificial tears or saline

Proportion of participants who discontinued medication and did not develop rebound SEI within 21 days (higher is favored) · epidemic keratoconjunctivitis

The review found no eligible studies for this question.

1 finding from 1 review

Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Any intervention vs artificial tears or saline

Proportion of participants who had evidence of adenoviral eradication within 14 days of treatment (higher is favored) · epidemic keratoconjunctivitis

1 finding from 1 review

Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Any intervention vs artificial tears or saline

Proportion of initially unaffected fellow eyes that had signs/symptoms of infection within 7 days of onset of signs/symptoms in the first eye (lower is favored) · epidemic keratoconjunctivitis

The review found no eligible studies for this question.

1 finding from 1 review

Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Any intervention vs steroid alone or plus levofloxacin

Mean number of days from treatment initiation to resolution of symptoms or signs (shorter is favored) · epidemic keratoconjunctivitis

1 finding from 1 review

Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

CBT interventions (CBT with and without exercise) vs control (standard care or sham treatments)

FoF (immediate postintervention)a · older adults (mean age minus 1 standard deviation is more than 60 years)

1 finding from 1 review

Cognitive behavioural therapy (CBT) with and without exercise to reduce fear of falling in older people living in the… 2023 · Cochrane Headline outcomes only
no estimate extracted
11 studies · 2357 participants
Moderate

CBT interventions (CBT with and without exercise) vs control (standard care or sham treatments)

FoF (sustainability of effects, up to 6 months' postintervention) · older adults (mean age minus 1 standard deviation is more than 60 years)

1 finding from 1 review

Cognitive behavioural therapy (CBT) with and without exercise to reduce fear of falling in older people living in the… 2023 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 1784 participants
Low

CBT interventions (CBT with and without exercise) vs control (standard care or sham treatments)

FoF (sustainability of effects, > 6 months' postintervention) · older adults (mean age minus 1 standard deviation is more than 60 years)

1 finding from 1 review

Cognitive behavioural therapy (CBT) with and without exercise to reduce fear of falling in older people living in the… 2023 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 1185 participants
Moderate

Yoga vs no treatment (both groups received standard medical therapy)

Treatment success as defined by the authors · people with inflammatory bowel disease

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Yoga vs no treatment (both groups received standard medical therapy)

Abdominal pain frequency or change in frequency · people with inflammatory bowel disease

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Yoga vs no treatment (both groups received standard medical therapy)

Abdominal pain intensity or change in intensity · people with inflammatory bowel disease

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Yoga vs no treatment (both groups received standard medical therapy)

Withdrawals due to adverse events · people with inflammatory bowel disease

1 finding from 1 review

Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 100 participants
Very low

Acceptance interventions for weight concern vs no weight management intervention

Change in weight (kg) · People wanting to quit smoking

3 findings from 1 review

Interventions for preventing weight gain after smoking cessation 2021 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 169 participants
Very low
Interventions for preventing weight gain after smoking cessation 2021 · Cochrane Headline outcomes only
MD 0
3 studies · 106 participants
Low
Interventions for preventing weight gain after smoking cessation 2021 · Cochrane Headline outcomes only
MD 0.7
2 studies · 76 participants
Very low